Tenet Healthcare clears short-term resistance, shares stay supported by bullish analyst consensus

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 19:29.

Tenet Healthcare Corp (US88033G4073) remains in focus on the NYSE with the shares trading around the upper end of their recent range. Short-term technicals point to resistance in the high 170s to low 180s, while Wall Street keeps a pronounced Buy tilt on the stock according to Zacks and Benzinga analyst data.Investing.com Canada technical overview for THC

What the latest signals show

Technical analysis from Investing.com Canada puts Tenet Healthcare at a daily Buy signal, with seven indicators on Buy and only one on Sell for the NYSE-listed shares.Investing.com Canada technical overview for THC The 14-day Relative Strength Index sits around 57.6, which is below overbought territory and consistent with moderate upward momentum in recent sessions.Investing.com Canada technical overview for THC

The same technical snapshot cites a MACD reading of roughly 0.32 for Tenet Healthcare, again in Buy territory on a daily basis.Investing.com Canada technical overview for THC A Fibonacci pivot level around 179.26 dollars underscores why the area just below 180 dollars has acted as a notable short-term reference point for traders watching the stock.Investing.com Canada technical overview for THC

Consensus remains clearly bullish

Beyond chart indicators, Wall Street’s stance on Tenet Healthcare is clearly constructive. Zacks reports an average brokerage recommendation of 1.39 on a 1 to 5 scale, placing the stock between Strong Buy and Buy based on 22 research firms covering the NYSE-listed hospital operator.Zacks analysis of Tenet Healthcare’s brokerage recommendations The same piece notes a Zacks Rank #2 (Buy), supported by positive revisions in earnings estimates over recent months.Zacks analysis of Tenet Healthcare’s brokerage recommendations

A Benzinga stock analysis report places the current 12?month price target band for Tenet Healthcare between 210 and 260 dollars, with an average around 233.38 dollars from covering analysts.Benzinga stock analysis report on Tenet Healthcare That mid?point implies roughly 30 percent upside from share levels near 180 dollars, underscoring why the stock continues to feature in growth?oriented healthcare portfolios.Benzinga stock analysis report on Tenet Healthcare

The business behind the stock

Tenet Healthcare generates its revenue primarily from acute care and specialty hospitals as well as a large network of ambulatory surgery centers across the United States.Benzinga stock analysis report on Tenet Healthcare According to Benzinga’s profile, the group operated around 50 hospitals at the end of 2025, alongside hundreds of outpatient facilities concentrated in the southern states.Benzinga stock analysis report on Tenet Healthcare

Beyond bricks?and?mortar care delivery, Tenet also runs its Conifer segment, which provides revenue cycle management solutions to hospitals and healthcare systems.Benzinga stock analysis report on Tenet Healthcare This mix of patient services and administrative outsourcing gives the company multiple levers for margin improvement and cash flow generation across its portfolio.

Where the shares trade today

Tenet Healthcare shares (US88033G4073) trade on the NYSE at around 181.03 US dollars as of 2026-06-23, 19:05 Eastern time according to recent price history data.StockScan price history for Tenet Healthcare The all?time high of 247.21 dollars was recorded in March 2026, while the 52?week low sits far below current levels, reflecting a marked multi?year recovery in the stock.StockScan price history for Tenet Healthcare

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data are based on sources believed to be reliable but cannot be guaranteed.